16. Muller-Fassbender H. Double-blind clinical trial of S-adenosylmethionine versus ibuprofen in the treatment of osteoarthritis. Am J Med
1987;83:81-3.
17. Glorioso S, Todesco S, Mazzi A, Marcolongo R, Giordano M, Colombo B, et al. Double-blind multicentre study of the activity of S-
adenosylmethionine in hip and knee osteoarthritis. Int J Clin Pharmacol Res 1985;5:39-49.
18. Marcolongo R, Giordano N, Colombo B, et al. Double-blind multicentre study of the activity of S-adenosylmethionine in hip and knee
osteoarthritis. Curr Ther Res 1985;37:82-94.
19. Domljan Z, Vrhovac B, Durrigl T, Pucar I. A double-blind trial of ademetionine vs Naproxen in activated gonarthrosis. Int J Clin
Pharmacol Ther Toxicol 1989;27:329-33.
20. Caruso I, Peitrogrand V. Italian double-blind multicentre study comparing S-adenosylmethionine, Naproxen, and placebo in the treatment
of degenerative joint disease. Am J Med 1987;83:66-71.
21. Vetter G. Double-blind comparative clinical trial with S-adenosylmethionine and indomethacin in the treatment of osteoarthritis. Am J
Med 1987;83:78-80.
22. Maccagno A. Double-blind controlled clinical trial of oral S-adenosylmethionine versus piroxicam in knee osteoarthritis. Am J Med
1987;83:89-94.
23. Konig B. A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis. Am J Med 1987;83:89-94.
www.meschinohealth.com
104
Meschino Health Comprehensive Guide to Accessory Nutrients and Essential Oils
Accessory Nutrients and Essential Oils
24. Berger R, Nowak H. A new medical approach to the treatment of osteoarthritis: report of an open phase IV study with ademetionine
(Gumaral). Am J Med 1987;83:84-8.
25. Tavoni A, Vitali C, Bombardieri S, Pasero G. Evaluation of S-adenosylmethionine in primary fibromyalgia: a double-blind crossover study.
Am J Med 1987;83:107-10.
26. Jacobsen S, Danneskiold-Samsoe B, Andersen RB. Oral S-adenosylmethionine in primary fibromyalgia: double-blind clinical evaluation.
Scand J Rheumatol 1991;20:294-302.
27. Di Benedetto P, Iona LG, Zidarich V. Clinical evaluation of S-adenosyl-L-methionine versus transcutaneous nerve stimulation in primary
fibromyalgia. Curr Ther Res 1993;53:222-9.
28. Mazzanti R, et al. On the antisteatosic effects of S-adenosyl-L-methionine in various chronic liver diseases: a multicentre study. Curr
Ther Res 1979;25:25-32.
29. Frezza M, Surrenti C, Manzillo G, Fiaccadori F, Bortolini M, Di Padova C. Oral S-adenosylmethionine in the symptomatic treatment of
intrahepatic cholestasis: a double-blind, placebo-controlled study. Gastroenterology 1990;99:211-5.
30. Adachi Y, et al. The effects of S-adenosyl-L-methionine on intrahepatic cholestasis. Jap Arch Int Med 1986;33:185-92.
31. Padova C, Tritapepe R, Padova F, et al. S-adenosyl-L-methionine antagonizes oral contraceptive-induced bile cholesterol
supersaturation in healthy women: preliminary report of a controlled randomized trial. Am J Gastroenterol 1984;79:941-4.
32. Frezza M, Pozzato G, Chiesa L, Stramentinoli G, di Padova C. Reversal of intrahepatic cholestasis of pregnancy in women after high
dose s-adenosyl-L-methionine administration. Hepatol. 1984;4:274-278.
33. Frezza M, Pozzato G, Pison G, et al. S-adenosylmethionine counteracts oral contraceptive hepatotoxicity in women. Am J Med Sci
1987;293:234-8.
34. Bombardieri G, Milani A, Bernardi L, Rossi L. Effects of S-adenosyl-L-methionine (SAM) in the treatment of Gilbert’s syndrome. Curr
Ther Res 1985;37:580-5.
35. Angelico M, Gandin C, Nistri A, Baiocchi L, Capocaccia L. Oral S-adenosyl-L-methionine (SAM) administration enhances bile salt
conjunction with taurine in patient with liver cirrhosis. Scand J Clin Lab Invest 1994;54:459-64.
36. Kakimoto H, Kawata S, Imai Y, et al. Changes in lipid composition of erythrocyte membranes with administration of S-adenosyl-L-
methionine in chronic liver disease. Gastroenterolia Japonica 1992;27:508-13.
37. Loguercio C, Nardi G, Argenzio F, Aurilio C, Petrone E, Grella A, et al. Effect of S-adenosyl-L-methionine administration on red blood cell
cysteine and glutathione levels in alcoholic patients with and without liver disease. Alcohol Alcoholism 1994;54:597-604.
38. Pascale RM, Marras V, Simile MM, Daino L, Pinna G, Bennati S, et al. Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-
methionine: a long-term study. Cancer Res 1992;52:4979-86.
39. Mato JM, Cámara J, Fernández de Paz, Caballería L, Coll S, Caballero AM, et al. S-adenosyl-L-methionine in alcoholic liver cirrhosis: a
randomized placebo-controlled, double-blind, multicentre clinical trial. J Hepatol 1999;30:1081-9.
40. Gatto G, Caleri D, Michelacci S, Sicuteri F. Analgesizing effect of a methyl donor (S-adenosylmethionine) in migraine: an open clinical
trial. Int J Clin Pharmacol Res 1986;6:15-7.
41. Reicks M, Hathcock JN. Effects of methionine and other sulfur compounds on drug conjugations. Pharmac Ther 1998;37:67-79.
42. Bodner RA, Lynch T, Lewiss L, Kahn D. Serotonin syndrome. Neurology 1995;45:219-23.
43. Bressa GM. S-adenosylmethionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand Suppl 1994;154:7-